-
1 month ago | 
cabotwealth.com | Michael Brush |MSN Money
Are promises made really promises kept, for President Donald Trump? No one really knows. So, cannabis equity investors remain depressed. They can’t get any bullish signals from the administration on Trump’s promised rescheduling – which was one reason they voted for him, if they did. But there is a way to deal with this uncertainty as a cannabis investor. Shift your focus to getting paid to wait.
-
2 months ago | 
cabotwealth.com | Michael Brush |MSN Money
These are dark days for cannabis investors, maybe the darkest ever. AdvisorShares Pure U.S. Cannabis (MSOS), one of the key benchmark exchange-traded funds in the space, is down 85% in the past five years against market gains of 80%. As has always been the case, the fate of cannabis stocks is much more about politicians than the leadership and results at cannabis companies. President Donald Trump promised game-changing policy reforms during the election.
-
2 months ago | 
cabotwealth.com | Ed Coburn
A letter from Cabot President Ed Coburn with his insights and perspectives on all things crypto-related and Cabot's five rules for investing in cryptocurrencies.
-
Oct 14, 2024 | 
cabotwealth.com | Michael Brush |MSN Money
Cannabis has the highest profile it has ever had as an election-year issue. This confirms my core thesis that powerful cultural momentum favors of cannabis reform. That’s bullish for cannabis stocks. Plus, once again, they’re extremely out of favor – another good reason to buy right now. Because politicians are involved, it’s tough to predict the timing of any reform that would boost cannabis stocks. But one thing is clear.
-
Sep 27, 2024 | 
cabotwealth.com | Michael Brush |MSN Money
Cannabis investors remain in a depressed state. Counterintuitively, this is a signal to buy the group. The best time to buy stocks is when they are widely hated, but plausible catalysts lie on the horizon. This is clearly the case with cannabis stocks now. Admittedly, with sentiment so negative, it’s hard to buy cannabis stocks. That resistance may be a signal to buy. As a general rule, some of your best stock purchase decisions will be the ones that are the hardest to make.
-
Aug 30, 2024 | 
cabotwealth.com | Michael Brush |MSN Money
Talk about a terrible week for cannabis investors. The Drug Enforcement Agency (DEA) Monday torpedoed the sector by announcing a move that will significantly delay favorable legal reform. What happened: The DEA now wants to hold a formal hearing on the Biden administration’s proposal to reschedule cannabis, before deciding what to do. The move dashed all hopes of rescheduling before the election – which many analysts had expected – since the hearing is set for December 2.
-
Aug 12, 2024 | 
cabotwealth.com | Michael Brush |MSN Money
Democrats have put together a cannabis dream ticket. Investors act like they haven’t even noticed. This seems like a big mistake. My key takeaway: Cannabis stocks look buyable in the current bout of dramatic weakness for the sector. Cannabis investors are notoriously bipolar. Right now, they are in a dark mood. That’s usually been the best time to add to positions, especially when there are potential catalysts on the horizon like now.
-
Jul 31, 2024 | 
cabotwealth.com | Michael Brush |MSN Money
Cannabis investors did exactly the wrong thing July 29 following the publication of a Fox News poll showing Vice President Kamala Harris has caught up to and surpassed Donald Trump in five key swing states. They sold the sector. The AdvisorShares Pure U.S. Cannabis ETF (MSOS) closed down for the day. Bad move, cannabis investors. Not only is Harris a better cannabis advocate than President Joe Biden, she’d obviously be more favorable to the sector than Trump.
-
Jul 11, 2024 | 
cabotwealth.com | Michael Brush |MSN Money
Cannabis stocks are thoroughly unloved and abandoned once again. But that will change quickly, and in a big way, if any of the potential big catalysts hit between now and the end of the year. No guarantees, but this is likely. Let’s consider the possible timeline for the biggest potential catalyst of them all, which is rescheduling.
-
Jun 28, 2024 | 
cabotwealth.com | Michael Brush |MSN Money
As the presidential election contest heats up, investors are laser-focused on the role of cannabis reforms in the contest. The big one is rescheduling of cannabis under the Controlled Substances Act (CSA) being pushed by the administration of President Joe Biden to shore up the youth vote. Polls show younger voters overwhelmingly support legalization. Rescheduling would give cannabis companies a fresh shot of cash by allowing them to deduct operating expenses on federal tax forms.